Form 4: NEXGEL Director Sells Shares Under Pre-Arranged Trading Plan

NEXGEL, Inc. Director Scott Robert Henry sold 3,000 shares of common stock on June 13, 2025, through a Rule 10b5-1 trading plan.

Summary

• Scott Robert Henry, a Director of NEXGEL, Inc. (NXGL), reported the sale of 3,000 shares of common stock.
• The transaction occurred on June 13, 2025.
• The shares were sold at a weighted average price of $2.5681 per share, with individual sales ranging from $2.5000 to $2.7000.
• The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following this transaction, Mr. Henry beneficially owns 129,053 shares of NEXGEL common stock directly.
• The shares sold were originally acquired by Mr. Henry in the open market on September 16, 2022.

Sentiment

Score: 5

Explanation: While insider selling can sometimes be viewed negatively, the execution under a Rule 10b5-1 plan indicates a pre-planned transaction rather than a reactive one, mitigating immediate negative sentiment.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not a reaction to recent non-public information.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces an insider's direct stake in the company.

Risks

• No specific risks to the company's operations or financial health are disclosed in this Form 4 filing. The primary risk is related to investor perception of insider selling.

Future Outlook

Not applicable, as this document does not contain forward-looking statements or guidance.

Industry Context

This filing is specific to an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: May interpret the sale as a slight reduction in insider confidence, though the 10b5-1 plan mitigates this.

Key Dates

Keywords

NEXGEL, NXGL, Form 4, insider trading, stock sale, director, Rule 10b5-1